Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

US STOCKS-The S&P 500 closes with a modest gain on Brexit deal, stimulus hopes

Published 12/25/2020, 02:00 AM
Updated 12/25/2020, 02:10 AM
© Reuters.

© Reuters.

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window.)
(Updates to market close, changes dateline, byline)
By Stephen Culp
NEW YORK, Dec 24 (Reuters) - The S&P 500 ended higher at the
close of a shortened session on Thursday as investors headed
into the long Christmas weekend with hopes that an imminent
stimulus agreement, a Brexit deal, and the ongoing vaccine
rollout will spell brighter days in the coming year.
All three major U.S. stock indexes ended in positive
territory.
While stocks tend to perform well in the closing days of
December, a phenomenon known as the Santa Claus rally, the
resurgent pandemic and upcoming Senate runoffs in Georgia have
clouded the outlook this year. The U.S. House of Representatives blocked President Donald
Trump's attempt to change a $2.3 trillion coronavirus relief and
government spending package after Trump insisted on $2,000
direct payments to Americans. The move cast doubt as to whether the package passed by
Congress on Monday would be signed into law and raised the
threat of a partial government shutdown.
"If (stimulus) doesn't get passed in some form or another it
could mean severe consequences for the unemployed," said Peter
Cardillo, chief market economist at Spartan Capital Securities
in New York.
Britain reached a trade deal with the European Union after
months of negotiations, just days before leaving one of the
world's largest trading blocs. "(The Brexit deal) might be acting as a buffer for the
market in the sense that it's counteracting the negativity of
the stimulus bill being stalled," Cardillo added.
More than one million Americans have now been vaccinated
against COVID-19 even as the pandemic continues to rage in the
United States and political leaders moved to guard against a
more contagious variant of the disease sweeping across Britain.
Unofficially, the Dow Jones Industrial Average .DJI rose
71.42 points, or 0.24%, to 30,201.25, the S&P 500 .SPX gained
13.25 points, or 0.36%, to 3,703.26 and the Nasdaq Composite
.IXIC added 33.62 points, or 0.26%, to 12,804.73.
Shares of Alibaba Group BABA.N dropped on news that China
had launched an investigation into the company as part of its
antitrust crackdown. American Airlines Group Inc AAL.O said it was moving
forward with plans to recall furloughed workers, even as
forthcoming payroll protections, part of the stimulus package,
was called into doubt. Its shares closed lower. Moderna Inc MRNA.O said that it expects its coronavirus
vaccine to be effective against a new variant of the disease
discovered in Britain. Even so, its shares have dipped.
Altimmune Inc ALT.O slipped after the U.S. Food and Drug
Administration issued a clinical hold on the company's
application to begin human testing of its single-dose COVID-19
vaccine, AdCOVID.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.